LSX World Congress is a meeting place for biotechs, big pharma companies, and investors. Milenko Cicmil is familiar with all three worlds as CEO of Tasca Therapeutics, an investor with Cure Ventures, ...

At this year’s LSX World Congress in Boston, an entire track was devoted to Obesity Science and Innovation, with pharma ...

Already a blockbuster therapy for advanced breast cancer and other indications like gastric cancer, Enhertu made revenues of ...

Investors were spooked by the miss, and shares in Nasdaq-listed Enanta were down around 11% having risen sharply in ...

AstraZeneca is the latest big pharma group to open up a Direct-To-Consumer (DTC) sales channel in the US, offering three of ...

Antibody specialist Genmab has continued its shift from out-licensing drugs to developing its own medicines with a deal to ...

Sarno discusses her favourite memory from Frontiers Health, as well as the importance of equity and accessibility for ...

Walmsley will step down from the board of directors of GSK at the end of the year, and will step down as CEO on 30th ...

Eli Lilly has selected Houston, Texas, as the location for a major new facility for active pharmaceutical ingredients (APIs) in the US that will support its fast-growing weight-loss business. The ...

uniQure's gene therapy for Huntington's has hit the mark in a clinical trial, raising hopes of the first treatment for the devastating neurodegenerative disease. Shares in the biotech rose sharply ...

President Donald Trump has given leading pharma manufacturers a 60-day deadline to come up with a most favoured nation (MFN) approach to drug pricing, or face consequences. Trump has sent letters to ...

Biologics have created revolutionary treatment options that have transformed the care journey for hundreds of millions of patients worldwide. In some cases, a painless injection is all that is now ...